These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9787749)

  • 21. Do conduct problems and sensation seeking moderate the association between ADHD and three types of stimulant use in a college population?
    Van Eck K; Markle RS; Flory K
    Psychol Addict Behav; 2012 Dec; 26(4):939-47. PubMed ID: 22428861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?
    Kaye S; Darke S
    Addiction; 2012 Mar; 107(3):467-77. PubMed ID: 22313101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dextropropoxyphene dependence: a cautionary note.
    Edwin T; Nammalvar N; Ramanujam V
    J Assoc Physicians India; 2001 May; 49():571-3. PubMed ID: 11361277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substance use disorders in adolescents with attention-deficit/hyperactivity disorder.
    Bukstein O
    Adolesc Med State Art Rev; 2008 Aug; 19(2):242-53, viii. PubMed ID: 18822830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current data on methamphetamine].
    Cottencin O; Rolland B; Guardia D; Karila L
    Rev Prat; 2012 May; 62(5):679-81. PubMed ID: 22730802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurologic Complications of Psychomotor Stimulant Abuse.
    Sanchez-Ramos J
    Int Rev Neurobiol; 2015; 120():131-60. PubMed ID: 26070756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood stimulant treatment and risk for later substance abuse.
    Fischer M; Barkley RA
    J Clin Psychiatry; 2003; 64 Suppl 11():19-23. PubMed ID: 14529326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ephedrine abuse among 36 female weightlifters.
    Gruber AJ; Pope HG
    Am J Addict; 1998; 7(4):256-61. PubMed ID: 9809129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Lynskey MT; Agrawal A
    Psychol Med; 2007 Sep; 37(9):1345-55. PubMed ID: 17407621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of admissions for primary stimulant dependence during 2001.
    Gunter TD; Arndt S; Wenman G
    Subst Use Misuse; 2006; 41(9):1277-86. PubMed ID: 16861178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of dopamine in drug dependence processes].
    Tassin JP
    Bull Acad Natl Med; 2002; 186(2):295-304; discussion 304-5. PubMed ID: 12145837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.
    Carlson PJ; Merlock MC; Suppes T
    Bipolar Disord; 2004 Oct; 6(5):416-20. PubMed ID: 15383134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids.
    Gillespie NA; Neale MC; Prescott CA; Aggen SH; Kendler KS
    Addiction; 2007 Jun; 102(6):920-30. PubMed ID: 17523987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute coronary syndrome and crystal methamphetamine use: a case series.
    Wijetunga M; Bhan R; Lindsay J; Karch S
    Hawaii Med J; 2004 Jan; 63(1):8-13, 25. PubMed ID: 15011896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addiction and dose response: the psychomotor stimulant theory of addiction reveals that hormetic dose responses are dominant.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(7):599-617. PubMed ID: 18709568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicity and abuse of prescribed stimulants.
    Spier SA
    Int J Psychiatry Med; 1995; 25(1):69-79. PubMed ID: 7649719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive efficiency in stimulant abusers with and without alcohol dependence.
    Lawton-Craddock A; Nixon SJ; Tivis R
    Alcohol Clin Exp Res; 2003 Mar; 27(3):457-64. PubMed ID: 12658111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.